Stockholders' Equity (Tables)

12 Months Ended

Jun. 30, 2013

Stockholders' Equity [Abstract]

Schedule Of Option Activity

		Weighted Average Exercise Price		Weighted Average Remaining Term to Vest in Years
Outstanding at beginning of period	9,363,720	$	20.52	3.3
Granted	444,766		41.11
Exercised	(3,432,800)		19.14
Forfeited	(59,550)		23.87
Outstanding at end of period	6,316,136	$	22.68	2.3
Exercise price range of granted options	31.61 - 43.63
Options exercisable at end of period	4,727,408	$	19.35

Schedule Of Activity Of Restricted Stock Units

		Weighted Average Grant-Date Fair Value		Weighted Average Remaining Term to Vest in Years
Outstanding at beginning of period	2,160,873	$	29.13	1.6
Granted	1,259,599		37.72
Vested*	(699,388)		29.00
Forfeited	(87,677)		30.15
Outstanding at end of period	2,633,407	$	33.25	1.4

Schedule Of Total Stock-Based Compensation Costs Incurred And Associated Tax Benefit Recognized

	2013		2012		2011
Cost of sales - capitalized as part of inventory	$	2,484	$	1,749	$	1,496
Selling, general and administrative expenses		30,552		25,201		26,163
Research and development expenses		5,121		3,636		3,150
Stock-based compensation costs		38,157		30,586		30,809
Tax benefit		(11,960)		(8,421)		(9,474)
Stock-based compensation costs, net of tax benefit	$	26,197	$	22,165	$	21,335